S-Sulfocysteine simplifies fed-batch processes and increases the CHO specific productivity via anti-oxidant activity  by Hecklau, Caroline et al.
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a  b  s  t  r  a  c  t
Industrial  fed-batch  cultivation  of mammalian  cells  is  used  for the  production  of  therapeutic  proteins
such  as  monoclonal  antibodies.  Besides  medium  ensuring  initial  growth,  feeding  is necessary  to  improve
growth,  viability  and  antibody  production.  Established  processes  include  a slight acidic  main  feed  and
a  separate  alkaline  feed  containing  l-tyrosine  and  l-cysteine.  Since  l-cysteine  is  not stable  at  neutral
pH,  a  new  derivative,  S-sulfocysteine,  was  tested  in  neutral  pH  feeds.  In  small  scale  fed-batch  processes,
the  S-sulfocysteine  process  yielded  a comparable  maximum  viable  cell  density,  prolonged  viability  and
increased  titer  compared  to  the  two  feed  system.  Bioreactor  experiments  conﬁrmed  the increase  in
speciﬁc  productivity.  In depth  characterization  of the monoclonal  antibody  indicated  no change  in the
glycosylation,  or  charge  variant  pattern  whereas  peptide  mapping  experiments  were  not  able  to detected-batch
onoclonal antibody
roductivity
ingle feed
any integration  of the  modiﬁed  amino  acid  in  the  sequence  of  the  monoclonal  antibody.  Finally,  the  mech-
anism  of action  of  S-sulfocysteine  was  investigated,  and  results  pointed  out  the  anti-oxidative  potential
of  the  molecule,  mediated  through  an  increase  in superoxide  dismutase  enzyme  levels  and  in  the  total
intracellular  glutathione  pool.  Finally,  we  propose  that  the increase  in speciﬁc  productivity  obtained  in
the  S-sulfocysteine  process  results  from  the  anti-oxidative  properties  of  the  molecule.
©  2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Large scale fed-batch cultures of mammalian cells are widely
sed to produce proteins for diagnostic, therapeutic and research
pplications (Birch and Racher, 2006). In fed-batch processes, the
edium is necessary to ensure the initial growth while one or more
eeds are added to improve cell growth, cell viability and protein
iter. To obtain a robust process, culture parameters like pH or dis-
olved oxygen should be kept stable after feeding, thus rendering
eutral pH feeds, highly desirable. The two main limitations for
he development of neutral pH feeds are the very low solubility
f l-tyrosine (Carta and Tola, 1996) and the lack of stability of l-
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cysteine. While a solution to improve the solubility of l-tyrosine
by using phosphotyrosine di-sodium salt (PTyr) has already been
described (Zimmer et al., 2014), the stabilization of l-cysteine
is more challenging. Indeed, l-cysteine is a sulphur-containing
amino acid which is oxidized to the dimer l-cystine in the pres-
ence of air, oxygen or metal containing catalysts such as copper
(Rigo et al., 2004). Whereas l-cysteine is freely soluble in water,
l-cystine has a reduced solubility of 0.112 g/L in water at 25 ◦C
(O’Neil et al., 2006) and often precipitates in neutral pH feeds. Due
to the essential role of cysteine for protein synthesis and cellular
metabolism, in particular as precursor of glutathione (GSH), taurine
and pyruvate (Stipanuk et al., 2006), several attempts have been
made to synthesize cysteine derivatives, for example, N-acetyl-l-
cysteine (NAC), its derivatives N-acetylcysteine amide (NACA) and
N-acetylcysteine ethyl ester (NACET). In CHO cell culture, NAC pro-
motes uptake of l-cystine from the growth medium and leads to a
rapid utilization for cellular GSH biosynthesis (Issels et al., 1988).
NACA and NACET were described as being transformed intracellu-
larly to NAC and l-cysteine, thus increasing intracellular GSH  and
providing anti-oxidant activity (Giustarini et al., 2012; Grinberg
et al., 2005). As precursor of l-cysteine, several thiazolidine
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Spin tube batch experiment in medium containing either l-cysteine or SSC. 1.5 mM SSC was added to a cysteine depleted CellventoTM CHO-220 and the performance
was  compared to the medium supplemented with 1.5 mM l-cysteine (n = 3). Suspension CHO cells were seeded at 2 × 105 cells/mL, incubated at 37 ◦C, 5% CO2, 80% humidity
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-cysteine and l-cystine concentration in the supernatant measured by UPLC after IA
easured by ion chromatography.
erivatives have also been developed like thiazolidine carboxylic
cid (TCA) (Debey et al., 1958) or L-2-oxo-thiazolidine-4-carboxylic
cid (OTC, Pro-cysteine) (Bjelton and Fransson, 1990). TCAs or 2-
ubstituted TCAs formed from the condensation of cysteine with
aturally occurring aldose monosaccharides, have been shown to
elease l-cysteine via non-enzymatic ring opening and to enhance
ntracellular GSH levels (Nagasawa et al., 1984; Roberts et al., 1987).
ll these derivatives were shown to act as prodrugs, releasing
ysteine spontaneously or after cleavage by speciﬁc enzymes like
eacetylases (Issels et al., 1988).
Results presented in this work demonstrate that S-sulfo-l-
ysteine (SSC) can be used as a source of l-cysteine in cell culture
edia and in neutral pH feeds added in fed-batch processes. To
ur knowledge, this is the ﬁrst time that SSC is used in this appli-
ation. Several months stability of the molecule in the feed, as
ell as a prolonged growth and an increased productivity of CHO
ells producing a monoclonal antibody (mAb), were observed.
he mechanism of intracellular cysteine release, involving redox
hemistry, as well as the anti-oxidative mechanism underlying the
ncrease in speciﬁc productivity are described.
. Materials and methods
.1. Solubility and stability of S-sulfocysteineSSC was synthesized according to published protocols (Segel
nd Johnson, 1963) or was purchased from Bachem (Bachem
G, Bubendorf, Switzerland). Investigation of the maximumernatant measured by UPLC after IAM treatment and AccQ•Tag derivatization. (C)
atment and AccQ•Tag derivatization. (D) Sulfate concentrations in the supernatant
solubility of SSC was  carried out in water or in a neutral pH
proprietary cell culture feed, containing 30 mM phosphotyrosine
di-sodium salt (Merck Millipore, Darmstadt, Germany, (Zimmer
et al., 2014)). The stability of either 15 mM SSC or 15 mM l-cysteine
was evaluated in the feed over 3 months and was compared to
the stability of the feed without addition of any cysteine source.
The impact of the storage temperature (room temperature and
4 ◦C) was  investigated. The stability was evaluated through visual
observation of the feed (color or precipitation) and through quan-
tiﬁcation of amino acids including SSC, l-cysteine and l-cystine
using the UPLC method described in ofﬂine analysis. The feed
medium was considered stable if the standard deviation of the
measured concentrations over time was  below 10%.
2.2. Cell culture
For batch and fed-batch cultures, a CHO suspension cell line
expressing a human mAb, was used. For batch studies, 1.5 mM SSC
was added to a neutral pH, lL-cysteine deﬁcient, CellventoTM CHO-
220. l-cysteine was  added at the same concentration in the control
condition. Batch experiments were performed in triplicate using
50 mL  spin tubes with a starting culture volume of 30 mL.  Incuba-
tion was carried out at 37 ◦C, 5% CO2, 80% humidity and an agitation
of 320 rpm.For fed-batch experiments, CellventoTM CHO-220 containing
1.5 mM l-cysteine was  used. Several SSC concentrations were
added to a neutral pH feed containing 30 mM phosphotyrosine di-
sodium salt as described elsewhere (Zimmer et al., 2014). In the
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Table  1
Physico-chemical characteristics of S-sulfocysteine in comparison to l-cysteine in water and chemically deﬁned feed. Solubility in water was  determined using infrared-based
residual mass determination, whereas solubility in the feed was  carried out by dissolving increasing concentrations of SSC in neutral pH feed. Stability was determined in
the  concentrated feed using SSC, l-cysteine and l-cystine quantiﬁcation by UPLC. The l-cysteine derivative was considered stable if the standard deviation of the measured
concentrations over three months was below 10%.
l-cysteine hydrochloride monohydrate S-sulfo-l-cysteine sodium salt
Formula C3H8ClNO2S × H2O C3H6NNaO5S2
CAS Number 7048-04-6 7381-67-1
◦
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fSolubility in water (25 C) >800 mM
Solubility in concentrated feed at pH 7.0 (25 ◦C) >800 mM
Stability in concentrated feed at pH 7.0 (4 ◦C) <24 h (1
ontrol condition, a separate feed containing 150 mM l-cysteine at
H 11.0 was used. Feeding was carried out in both conditions at
ays 3, 5, 7, 10 and 14 at the following v/v ratios (3, 6, 6, 6 and 3%).
lucose was quantiﬁed daily and adjusted to 4 g/L using a 400 g/L
lucose solution.
For spin tube fed-batch experiments, the starting culture vol-
me  was 34 mL  with a seeding density of 2 × 105 cells/mL. Five
eplicates for each condition were performed. Incubation was  car-
ied out at 37 ◦C, 5% CO2, 80% humidity and an agitation of 320 rpm.
Small scale bioreactor runs were performed in 1.2 L DasGip glass
essels. pH was controlled at 6.95 + − 0.15. The dissolved oxygen
oncentration was controlled at 50% air saturation by sparging with
ure oxygen and air via an open pipe sparger. Temperature was  set
t 37 ◦C and shifted from 37 ◦C to 33 ◦C on day 5 of the culture.
gitation was maintained at 140 rpm using a marine impeller.
.3. Ofﬂine analysis
The viable cell density (VCD) and viability were evaluated with
 ViCell XR (Beckman Coulter, Fullerton, CA). Metabolite concen-
rations were monitored using a Cedex Bio HT (Roche Diagnostics,
annheim, Germany) based on spectrophotometric and turbido-
etric methods. Quantiﬁcation of native and modiﬁed amino acids
as carried out via UPLC after derivatization with the AccQ•Tag
ltra® reagent kit. Derivatization, chromatography and data anal-
sis were carried out following the supplier recommendations
Waters, Milford, MA). Quantiﬁcation of sulfate was carried out
sing ion chromatography with a Thermo ICS1100 system. Brieﬂy,
ell culture media samples were diluted in water, injected and
eparated during 1 hour using a Thermo HPIC Ionpac—AG 14 pre-
olumn and a HPIC Ionpac—AS14 column maintained at room
emperature. A solution of 1.3 mM NaHCO3 and 1.4 mM Na2CO3
as used as eluent with a ﬂow rate of 1.5 mL/min. Detection was
erformed using a suppressed conductivity detector and data anal-
sis was performed using standard curves with Chromeleon 6.80
Thermo Fisher Scientiﬁc, Waltham, MA).
.4. Speciﬁc productivity
The productivity per cell per day was calculated daily by dividing
he titer by the corrected integral VCD to take into account the
ilution resulting from feeding. The overall speciﬁc productivity
as determined by calculating the slope from the linear regression
etween titer and corrected integral VCD.
.5. Intracellular ROS quantiﬁcation
Intracellular reactive oxygen species (ROS) were quantiﬁed
sing 6-carboxy-2′,7′-dichlorodihydroﬂuorescein di-acetate stain-
ng (Carboxy-H2DCFDA, Life technologies, Carlsbad, CA). The
ncrease in ﬂuorescence due to oxidative reactions was  deter-
ined using a ﬂuorescence reader (Perkin Elmer, Waltham, CA).
or these experiments, measurements were performed during
ed-batch processes comparing the control and the 15 mM SSC300 g/L (=1300 mM)
13.4 g/L (=50 mM)
>3  months (15 mM)
conditions. Samples were taken daily and analyzed immediately.
Therefor, 3 × 105 cells were centrifuged (1200 rpm, 5 min) and
either resuspended in PBS (negative control) or loaded with 50 M
Carboxy-H2DCFDA, followed by a 20 min  incubation at 37 ◦C and
1000 rpm. Cells were then centrifuged, resuspended in PBS and
analyzed using the plate reader.
2.6. Intracellular amino acid and total glutathione quantiﬁcation
To quantify intracellular amino acids and total glutathione, cells
were washed three times in cold PBS and frozen at −20 ◦C for fur-
ther analysis. To inhibit the activity of potential Cys-converting
enzymes, 15 × 106 cells were lysed in 100 l of PhosphoSafeTM
reagent (Merck Millipore, Darmstadt, Germany) containing four
phosphatase inhibitors (sodium ﬂuoride, sodium vanadate, -
glycerophosphate and sodium pyrophosphate) and supplemented
with 20 mM iodoacetamide (IAM, alkylation of all enzymes con-
taining one cysteine in their active site). The amino acid and
total glutathione concentrations (GSH + oxidized glutathione GSSG)
were determined using the UPLC method described previously and
data were normalized with the total protein concentrations deter-
mined using the Bradford method.
2.7. Mechanism of cysteine release from S-sulfocysteine
The chemical interaction between SSC and GSH was determined
by incubating equimolar concentrations of both molecules in water
at neutral pH, room temperature, during 30 min or 3 h. To mimic
intracellular behavior, 15 × 106 cells were lysed in PhosphoSafeTM
(Merck Millipore, Darmstadt, Germany) and spiked to the mixture,
the reaction being stopped by addition of IAM. The products of the
reaction were quantiﬁed using the amino acid method described
previously and identiﬁed using mass spectrometry (Q-Exactive,
Thermo Fisher Scientiﬁc, Waltham, MA). Data are presented nor-
malized to the amount of SSC and GSH added to the reaction.
2.8. mAb puriﬁcation and characterization
IgG were puriﬁed from the supernatants using PureProteomeTM
protein A magnetic beads (Merck Millipore, Darmstadt, Germany)
and eluted with 90% 200 mM glycine pH 3.0 and 10% 1 M Tris pH
8.5 according to the manufacturer protocol. The quantiﬁcation was
performed using the Bradford method and a puriﬁed IgG as stan-
dard (Sigma–Aldrich, St Louis, MO).
N-glycan quantiﬁcation was performed as described elsewhere
(Zimmer et al., 2014). Distribution of charge variants was  deter-
mined by capillary isoelectric focusing using the Beckman Coulter
PA800 and the corresponding manufacturer protocol.
For peptide mapping analysis and search for SSC containing pep-
tides, samples were prepared using a slightly modiﬁed RapiGestTMSF based protocol (Waters, Milford, MA). Brieﬂy, 50 g of each
sample were mixed with a ﬁnal concentration of 0.1% RapiGestTM
SF. Alkylation was  performed with 20 mM IAM (no reduction was
performed to maintain disulﬁde bridges intact). Finally 1.5 L of
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Fig. 2. Spin tube fed-batch experiment with neutral pH feed containing SSC. Different SSC concentrations (2.5, 5, 10, 15 mM)  were integrated in the main feed with 30 mM
PTyr2Na+ at neutral pH (single feed system). In the control condition, l-cysteine was added separately in an alkaline feed (n = 4) at a molar concentration equivalent to 15 mM
SSC.  Suspension CHO cells were seeded at 2 × 105 cells/mL, incubated at 37 ◦C, 5% CO2, 80% humidity and agitated at 320 rpm. Feed was added at 3% (v/v) at day 3 and 6% (v/v)
a ernat
m conce
d atogra
a
i
a
t
u
Mt  days 5, 7 and 10. (A) VCD, (B) cellular viability and (C) IgG concentration in the sup
easured by UPLC after IAM treatment and AccQ•Tag derivatization. (E) l-cystine 
erivatization. (F) Sulfate concentration in the supernatant measured by ion chrom
 1 g/L  trypsin solution were added, followed by an overnight
ncubation at 37 ◦C. After digestion, the sample was  acidiﬁed by
ddition of 0.5% triﬂuoroacetic acid and analyzed by LC–MS using
he ESI positive mode. NanoLC–MS analysis was  accomplished
sing a nanoAcquity UPLC coupled to a Synapt G1HDMS (Waters,
ilford, MA). 0.1% formic acid in water was used as solvent A andant measured by a turbidometric method. (D) SSC concentration in the supernatant
ntration in the supernatant measured by UPLC after IAM treatment and AccQ•Tag
phy.
0.1% formic acid in acetonitrile as solvent B. Tryptic peptides were
injected and trapped for 4 min  on a Symmetry C18 pre-column
(5 m,  180 m × 20 mm,  Waters) with a ﬂow rate of 10 L/min.
Separation was  performed using an UPLC 1.7 m BEH130 column
(C18, 75 m × 100 mm,  Waters) with a ﬂow rate of 450 nL/min, one
linear gradient (3–45% B for 70 min) and holding at 95% B for a fur-
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Fig. 3. Bioreactor fed-batch experiment with neutral pH feed containing SSC. 15 mM SSC and 30 mM PTyr2Na+ were integrated in the neutral main feed (single feed) (n = 5).
Feed  was  added at 3% (v/v) at day 3 and 6% (v/v) at days 5, 7, 9 and 14. In the control condition, l-cysteine was added separately in an alkaline feed (n = 2). (A) VCD, (B) cellular
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siability and (C) IgG concentration in the supernatant measured by a turbidometric 
nd  AccQ•Tag derivatization. (E) l-cystine concentration in the supernatant measur
n  the supernatant measured by photometric method.
her 5 min  before returning to 3% B for 15 min. MS  spectra were
cquired from m/z 50 to 1600. Extracted ion chromatograms were
nalyzed manually for each cysteine containing peptide. Since no
eduction was performed, most of the peptides were found linked
hrough disulﬁde bridges. Relative intensities of alkylated peptides
corresponding to free cysteine containing peptides of the mAb)
nd free cysteine containing peptides (resulting from the in-source
ragmentation of putative SSC containing peptides of the mAb)
ere calculated with the average of the 3 highest peptide inten-
ities.d. (D) SSC concentration in the supernatant measured by UPLC after IAM treatment
UPLC after IAM treatment and AccQ•Tag derivatization. (F) Ammonia concentration
2.9. mRNA extraction and qPCR
The relative mRNA expression level of genes involved in oxida-
tive, anti-oxidative and cysteine metabolism was determined using
CHO qPCR assay or array plates. Total RNA was extracted from
viable cells at different time points of the fed-batch process using
RNeasy mini/midi kits (Qiagen, Hilden, Germany). Contaminat-
ing genomic DNA was removed using the RNAse-Free DNase Set
and cDNA was obtained using the RT2 First Strand Kit as per the
manufacturer’s instructions. Relative gene expression was evalu-
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Fig. 4. Impact of SSC-containing feed on the quality attributes and sequence of the
monoclonal antibody. (A) Glycosylation pattern determined using the 2-AB label-
ing  method. (B) Charge variant distribution obtained using IEF. (C) Strategy used8 C. Hecklau et al. / Journal of
ted by quantitative PCR on a 7500 real-time PCR system (Applied
iosystems, Darmstadt, Germany) with either predesigned RT2
roﬁler PCR Array or RT2 qPCR primer assays directed against
amster genes, using the SYBR Green technology (Qiagen, Hilden,
ermany). Data were interpreted for each target gene in com-
arison with endogenous GAPDH levels as control. The relative
mount of target genes in each sample was calculated in compar-
son with the calibrator sample (normal fed-batch process using
ysteine in a separate pH 11.0 feed) applying the Ct method.
he magnitude of gene induction was calculated using the formula
−Ct = 2−(CtSSCProcess−CtCysteineProcess) and a difference in rela-
ive mRNA expression level of at least two fold was  considered as
ifferentially expressed.
.10. Western blot
CHO cells were washed three times with cold PBS and cell pel-
ets were lysed in a buffer containing 8.3 M urea, 2 M thiourea,
% CHAPS, 50 mM DTT and 24 mM spermine (all obtained from
igma–Aldrich, St Louis, MO). After centrifugation (16 000 g, 1 h,
0 ◦C), supernatants were recovered and stored at −80 ◦C. Pro-
eins were quantiﬁed using a Bradford assay. NuPAGE-western
lotting was carried out according to standard procedures (Life
echnologies, Carlsbad, CA). Samples were separated on 4–12%
is-Tris NuPAGE gels and blotted on a PVDF membrane using
he iBlot system. The following primary antibodies were used for
mmunoblotting analyses: anti SOD-1 (Origene, Rockville, MD,  Cat.
o. TA343111, 1/1000), anti SOD-2 (Cell Signaling Technology,
anvers, MA,  Cat. no. 13141S, 1/1000). A peroxidase-conjugated
oat anti-rabbit secondary antibody was obtained from Jackson
mmunoresearch Laboratories (West Grove, PA) and the chemi-
uminescence detection kit was from Pierce (Life Technologies,
arlsbad, CA). Western blot signals were acquired with a CCD cam-
ra (Chemidoc XRS, Biorad, Munich, Germany) and band volume
as quantiﬁed using the Biorad Quantity One software. GAPDH
Cell Signaling Technology, Danvers MA,  Cat. no. 2118, 1/1000) was
sed as loading controls.
.11. Statistics
Data are expressed as means ± SEMs. For cell culture exper-
ments, the area under the curve of each technical replicate
as calculated and statistical differences between groups were
ssessed by using a two-tailed nonparametric Mann–Whitney test
or single comparison, or a Kruskall–Wallis test for multiple com-
arisons. P-values of less than 0.05 were considered signiﬁcant.
tatistical and graphic analyses were performed with Prism 6 soft-
are (GraphPad Software Inc, La Jolla, CA).
. Results
.1. Solubility and stability of S-sulfocysteine in water and
hemically deﬁned feed at pH 7.0
To investigate the physico-chemical properties of SSC, solubility
nd stability tests were carried out in water and in concentrated,
eutral pH, proprietary feed. As shown in Table 1, SSC was  soluble
p to 1.3 and 2.3 M in water at room temperature and 37 ◦C respec-
ively, whereas only 50 mM SSC were soluble in the pH 7.0 feed.
n water, SSC was  stable at acidic (pH 3.0) and neutral pH (pH 7.0),
hereas a spontaneous dissociation leading to cysteine release and
ystine formation was observed at alkaline pH (pH 11.0) (Supple-
entary Fig. 1A). Investigation of the stability in the feed at pH
.0 was performed at 15 mM SSC (target concentration for cell cul-
ure experiments) and revealed no visible precipitation or change
n color during three months. The quantiﬁcation of SSC indicatedto  detect putative SSC integration into the sequence of the mAb  using a modiﬁed
peptide mapping experiment and ESI positive mass spectrometry analysis.
no signiﬁcant decrease of the SSC concentration at 4 ◦C or room
temperature protected from light. No buildup of either l-cysteine
or l-cystine was detected over the three months storage period.
Therefor, SSC was  considered to be stable at least during three
months in neutral pH feed. In contrast, feed containing 15 mM l-
cysteine showed a precipitation after less than 24 h due to l-cystine
formation and interaction with other metals like iron and copper
(data not shown).
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Sig. 5. Mechanism of cysteine release from SSC. Equimolar concentrations of SSC 
bsence of cell lysate. Released products were quantiﬁed by UPLC after IAM treatme
oncentrations (cysteine and glutathione moiety respectively). The identiﬁcation of
.2. Use of S-sulfocysteine to replace cysteine in batch
xperiments
The capacity of SSC to replace l-cysteine was  investigated in
atch experiments. Cultivation of a CHO suspension clone with
.5 mM SSC showed a similar maximum VCD of approximatively
50 × 105 cells/mL and a prolonged viability maintained over 90%
t day 7 compared to the control condition containing 1.5 mM l-
ysteine. (Fig. 1A). During the exponential growth phase (day 0 to
ay 5), 42% of the SSC were consumed whereas further 48% were
onsumed between day 5 and 7 (Fig. 1B). In the SSC condition, no
ree l-cysteine was detected throughout the experiment, whereas
n increase in extracellular cystine and sulfate was detected after
ay 5 and day 3 respectively (Fig. 1C and D). These results sug-
est that SSC may  either be taken up by the cells and processed
ntracellularly, resulting in release of excess sulfate; or be metab-
lized extracellularly to another derivative, distinct from cysteine
r cystine. At day 0 of the control condition, 420 M cystine and
14 M free cysteine were detected, accounting for only 64% of the
nitial cysteine concentration (1.5 mM).  This indicates that the oxi-
ation of cysteine to cystine is only partial and that 36% of the added
ysteine react with other compounds of the cell culture medium,
hus lowering the bioavailable amount. These interactions are most
ikely absent when SSC is used as replacement for cysteine since 98%
f the theoretical concentration is measured at day 0. Finally, since
he lack of cysteine or cystine in the medium led to immediate cell
eath (data not shown), these data suggest that SSC can be used as
 replacement for l-cysteine in batch experiments.
.3. Dose response of S-sulfocysteine in a spin tube fed-batch
rocess
The use of SSC was then tested in fed-batch experiments in
pin tubes. In these experiments, CellventoTM CHO-220 containing
.5 mM l-cysteine was used for both, the control and the test condi-
ions. In the control fed-batch process, cysteine was added through
n alkaline separate feed (at a concentration equimolar to 15 mM
SC), whereas increasing SSC concentrations were added directlySH were incubated in water at neutral pH during 30 min  or 3 h in the presence or
 AccQ•Tag derivatization and are presented as percentage of the initial SSC or GSH
ys, GSH, GS-SO3 and GSSG was conﬁrmed by LC–MS/MS.
in a one feed system at neutral pH (concentrations ranging from
2.5 mM to 15 mM  SSC). Maximum VCD of all tested SSC concentra-
tions were comparable to the control (130 × 105 cells/mL, Fig. 2A).
The viability was  maintained above 50% for two  additional days for
SSC concentrations equal or above 5 mM (Fig. 2B). Signiﬁcant higher
ﬁnal titers (+32%, p-value = 0.0023, Kruskall Wallis) were measured
with SSC concentrations ranging from 5 to 15 mM compared to the
control (Fig. 2C). When looking at the remaining SSC concentra-
tion in the supernatant, a clear consumption/metabolisation of the
molecule was  detected (Fig. 2D). In contrast to the control condi-
tion, where the addition of cysteine induced a rapid oxidation to
cystine after feeding, no conversion to either cysteine (data not
shown) or cystine was detected extracellularly until day 5 for the
SSC conditions (Fig. 2E). After day 5, a dose dependent increase in
the cystine concentration was observed in the supernatant and may
be associated to either an export of the amino acid from the intra-
cellular compartment, or an active conversion in the supernatant.
Finally, the increase in sulfate release after day 7 was  correlated
with SSC concentrations (Fig. 2F), indicating a conversion of SSC to
cysteine and sulfate. Overall, these data demonstrate that SSC can
be used as a source of cysteine/cystine in fed-batch processes.
3.4. Use of S-sulfocysteine in fed-batch bioreactor processes
To test whether a single feed process integrating SSC as cysteine
source can be used in a fully regulated and automated system, lab
scale bioreactor cultivation experiments were performed. Compa-
rable maximum VCD of 150 × 105 cells/mL were observed in the
control and 15 mM SSC condition (Fig. 3A), whereas prolonged
viabilities were detected when using the l-cysteine derivative
(Fig. 3B). 78% higher ﬁnal titers were obtained with 15 mM SSC
(Fig. 3C), resulting in a 1.7 fold increase of the mean speciﬁc pro-
ductivity. Whereas SSC was signiﬁcantly consumed after each feed
addition (Fig. 3D), the concentration of free l-cystine in the super-
natant decreased constantly within the tested conditions, whereas
the amount was  maintained at higher levels in the control condition
(Fig. 3E). Ammonia concentrations were lower using the cysteine
derivative compared to the control during the whole culture period
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Fig. 6. Anti-oxidative properties of SSC. (A) Intracellular reactive species were quantiﬁed during a fed-batch by labeling the cells with carboxy-H2DCFDA. A lower ﬂuorescence
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as  quantiﬁed in cell lysates using UPLC after IAM treatment and AccQ•Tag derivat
Fig. 3F). Finally, these data point out that SSC can be used as a
ource of cysteine in bioreactor controlled processes.
.5. Impact of S-sulfocysteine on the mAb sequence and critical
uality attributes
To evaluate the impact of SSC containing feeds on the mAb  qual-
ty attributes, glycosylation and charge variants were monitored at
ay 12 (viability >90%). The glycosylation pattern obtained in both,
he control and SSC conditions, showed no signiﬁcant change in
he main glycoforms, with approximatively 60% of G0F and 28% of
1F glycans. Minor forms were also similar as shown in Fig. 4A.
egarding charge variant distributions, the main peak accounted
or 68.5 ± 0.5% and 66.0 ± 2% for the control and SSC condition
espectively. Acidic and basic forms were found to be similar in both
onditions with approximatively 26 and 6% respectively (Fig. 4B).
To evaluate if SSC can be integrated as an unmodiﬁed amino acid
n the mAb, peptide mapping experiments were performed. Anal-
sis of a commercial S-sulfated peptide, used as positive control,
ndicated that the sulfate moiety present on the cysteine residue
as released in-source in electrospray positive ionization mode,
hus conﬁrming results obtained in the literature for tyrosine o-
ulfation (Onnerfjord et al., 2004; Salek et al., 2004). To overcome
his technical limitation, a new sample preparation was  developed
ased on a subtractive strategy used to determine the sites of tyro-
ine o-sulfation in proteins (Yu et al., 2007). As summarized in the
ig. 4C, non-reduced conditions and IAM were used to alkylate only-1 and SOD-2 during a fed-batch process monitored using a RT2 Proﬁler PCR Array.
tion at the protein level using Western blot. (D) Total free glutathione (GSH + GSSG)
n.
free cysteine residues. S-sulfated peptides and disulﬁde bridges
were not impacted by the treatment. Mass spectrometry analysis of
peptides in ESI positive mode induced an in-source fragmentation
of the sulfate moiety of putative SSC containing peptides, result-
ing in free cysteine containing peptides. With this method, most
of the cysteine containing peptides were found involved in disul-
ﬁde bridges, whereas several cysteine containing peptides where
found alkylated (i.e. free cysteine containing peptides in the mAb).
The relative intensities of these peptides were below 3.5% when
compared to the average of the three highest peptide intensities.
To detect possible SSC containing peptides, extracted ion chro-
matograms were performed manually for all cysteine containing
peptides, revealing one positive hit with a relative intensity below
0.5% (peptide n◦ 6, Supplementary Table 1). This peptide was  found
in both, the SSC and the control condition, indicating that it may
correspond to an endogenous S-sulfation, independent of the cul-
ture condition. Altogether, these results suggest that the use of SSC
has no impact on the mAb  sequence or its quality attributes.
3.6. Mechanism of cysteine release from S-sulfocysteine
The essential role of cysteine for cell growth was demonstrated
in batch experiments, where proliferation was completely inhib-
ited in cysteine depleted media. Since the addition of SSC restored
the growth, several experiments were designed to understand the
mechanism of cysteine production from SSC. When looking at cell
culture supernatants of fed-batch experiments, neither cysteine,
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or cystine was detected at signiﬁcant levels (Fig. 3E), whereas
 dose dependent increase in sulfate was monitored indicating
hat SSC was  actively cleaved. The absence of free cysteine in
he supernatant may  be explained by complexation with other
edia components like pyruvate forming thiazolidine complexes
Cavallini, 1951), but current quantiﬁcation data invalidated this
ypothesis (data not shown). To demonstrate a possible intracel-
ular enzymatic cleavage, SSC was incubated with fresh cell lysates
r cell lysates previously alkylated with IAM to inhibit the activ-
ty of enzymes containing a cysteine residue in their active center.
hereas 72.5% of the spiked SSC was metabolized by fresh cell
ysates after 30 min, the previous alkylation of the lysates limited
he SSC cleavage to 4%. These results suggest that cysteine con-
aining intracellular enzymes are able to use SSC as substrate. To
nderstand the underlying mechanism, SSC was incubated with
SH, the major intracellular thiol molecule, with or without lysate
Fig. 5). The results indicated a pH dependent (Supplementary Fig.
C), thiol–disulﬁde exchange between GSH and SSC leading to the
ormation of GSSG and the mixed disulﬁdes cysteine glutathione
GS-Cys) and sulfoglutathione (GS-SO3). The identiﬁcation of these
eaction products was conﬁrmed by LC–MS/MS (Supplementary
ile 1). The addition of lysates demonstrated an enhanced metab-
lization of SSC but decreased levels of mixed disulﬁdes indicating
 reduction reaction leading to the formation of cysteine and GSH.
inally, the presented results suggest an intracellular cleavage of
SC via interaction with GSH to produce mixed disulﬁdes, which
ay  serve as a cysteine pool being recovered through the enzyme
ctivity of e.g. oxidoreductases.
.7. Intracellular anti-oxidative properties of S-sulfocysteine and
mpact on titer
To further understand the mechanism of prolonged growth
nd increased productivity in the fed-batch process using SSC,
valuation of intracellular ROS was performed using a reactive ﬂu-
rescent dye. The results indicated that the ﬂuorescence intensity
f Carboxy-H2DCFDA labelled cells was reduced after day 10 in
he SSC containing process compared to the control, where cys-
eine was added through the alkaline feed (Fig. 6A). The difference
etween both conditions even increased with process progres-
ion until day 17. These results suggest that SSC may  increase the
ulture duration and titer of CHO cells either through lower oxida-
ive properties or through activation of anti-oxidative mechanisms.
o further understand the mechanism of action of the molecule,
icroarrays for anti-oxidative, sulfur- or cysteine-related enzyme
ranscripts were performed. Out of the 122 genes assessed with
PCR, 16 genes exhibited a low or undetectable mRNA expression
evel (deﬁned as Ct >35), including genes involved in cysteine syn-
hesis or anti-oxidative mechanisms. From the measurable gene
ranscripts, the expression level of the vast majority were highly
imilar between the conditions, indicating no change in e.g. GSH or
ulfur-related enzymes or antioxidant enzymes from the peroxire-
oxin family (Supplementary Fig. 2). Aspartate aminotransferase,
-mercaptopyruvate sulfurtransferase and cysteine sulﬁnic acid
ecarboxylase, three enzymes involved in the degradation of cys-
eine to form anti-oxidative molecules (pyruvate and taurine),
ere not transcriptionally regulated either (Supplementary Fig. 2).
inally, this screening indicated an up-regulation of a thioredoxin-
nteracting protein, as well as two superoxide dismutase (SOD)
nzymes involved in ROS elimination (Fig. 6B). The impact of SSC
n the SOD family was further validated using western blot analysis
f different time points in a fed-batch process (Fig. 6C). The results
onﬁrmed the time-dependent up-regulation of SOD-1 and SOD-2
n the SSC containing process. Finally, since GSH is the major cellular
ntioxidant, the total free glutathione pool was monitored intra-
ellularly during control and SSC containing fed-batch processeshnology 218 (2016) 53–63 61
(Fig. 6D). Results indicated a signiﬁcantly higher free glutathione
pool when using SSC, giving further evidence supporting the anti-
oxidative properties of SSC.
4. Discussion
l-cysteine is a key amino acid for cell growth, maintenance
and protein production. It plays a key role as sulfur source and is
the limiting factor for the synthesis of GSH, the main intracellular
antioxidant. Cysteine can be metabolized to key intermediates like
taurine and pyruvate (Stipanuk et al., 2006) and is involved in fold-
ing and stabilization of proteins via disulﬁde bond formation (Liu
and May, 2012). In fed-batch processes, l-cysteine is often added
in its disulﬁde form cystine, which has a very low solubility at neu-
tral pH and thus has to be dissolved in alkaline concentrated feeds
to meet cellular requirements. In order to simplify next generation
fed-batch processes, a new strategy using SSC was developed to
allow integration of a cysteine source into a single, neutral pH feed.
In the SSC molecule, the highly reactive thiol group of cysteine is
blocked by a sulfate group, thus lowering the reactive potential of
the molecule toward metals like copper and iron (Panossian et al.,
1979; Rigo et al., 2004) as well as oxidation (Jeong et al., 2011).
The presented results demonstrate that the modiﬁed amino acid
is stable in neutral pH feeds, allowing a storage over three months
at both, room temperature and 4 ◦C, without release of cysteine or
cystine and without change in color. The stability of SSC was shown
to be increased with decreasing pH and the ideal medium/feed
formulation has to be poor in other thiol compounds to prevent
thiol-disulﬁde interactions (Yoshiba-Suzuki et al., 2011).
In cell culture batch experiments, SSC was  able to replace l-
cysteine without negative impact on growth or titer. Since sulfate
was released in the supernatant, it can be concluded that the
molecule was  cleaved to form cysteine. The absence of signiﬁcant
cysteine and cystine release in the supernatant early in the cul-
ture suggested an intracellular cleavage mechanism. Whereas SSC
was never detected intact intracellularly (data not shown), exper-
iments were performed to mimic  the fate of the molecule in cells.
In vitro, the incubation of SSC with GSH led to a rapid formation
of GSSG, GS-Cys and GS-SO3. These spontaneous thiol-disulﬁde
exchange products were already described in the literature. GS-
Cys is a known product of oxidation of GSH and cysteine in PBS
(Yoshiba-Suzuki et al., 2011), whereas GS-SO3 was  found in vivo
in several studies (Robinson and Pasternak, 1964; Togawa et al.,
1988; Waley, 1959). Increasing amounts of mixed disulﬁdes were
detected over time, suggesting that these compounds may  serve
as storage for cysteine equivalents intracellularly (Togawa et al.,
1988). When SSC, or the mixture SSC/GSH, was  spiked into cell
lysates, a complete metabolisation of SSC was  observed within min-
utes. In parallel, the concentration of mixed disulﬁdes decreased,
while cysteine was  produced. The prior-incubation of the cell
lysate with IAM inhibited SSC metabolisation to more than 90%.
These results indicated that GS-Cys, GS-SO3 and potentially SSC
are substrates of intracellular enzymes, which can be inhibited by
IAM treatment. Careful review of the literature pointed out that
the thiol–disulﬁde oxidoreductase glutaredoxin (GRX) is able to
cleave the mixed disulﬁde of SSC/GSH (Gladyshev et al., 2001)
through deglutathionylation (Gallogly and Mieyal, 2007) and that
its activity can be inhibited by IAM treatment (Gladyshev et al.,
2001). The hypothesis that SSC is able to produce cysteine intra-
cellularly is further supported by studies in E. coli where SSC is
produced in vivo from o-acetylserine and thiosulfate and serves as
a component of the cysteine biosynthetic pathway (Nakatani et al.,
2012). In these studies, GRX as well as thioredoxin (TRX) isoforms
were able to reduce SSC in cysteine and the released sulﬁte was
used as a sulfur source to produce additional l-cysteine molecules
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Nakatani et al., 2012). Although the sulfur assimilation and cys-
eine synthesis pathways are highly different in bacterial and plants
ompared to mammalian systems, these results suggest a possi-
le mechanism of mixed disulﬁde cleavage in mammalian cells
xpressing both GRX and TRX oxidoreductases. Altogether, the
escribed results suggest that SSC can be taken up by CHO cells
nd once inside the cells, the molecule can interact with GSH lead-
ng to the formation of mixed disulﬁdes, which can be reduced back
o cysteine by the action of GRX and or TRX systems.
When used in fed-batch processes, SSC was combined with
hosphotyrosine di-sodium salt (Zimmer et al., 2014) in a neutral
H, single feed. The feeding was simpliﬁed since only one feed solu-
ion was added to the medium without impacting the pH and the
issolved oxygen regulation. The process was scaled up from spin
ube experiments to 1.2 L bioreactors without change in perfor-
ance. The optimal concentration of SSC (15 mM)  demonstrated
 positive impact on the culture duration and the ﬁnal titer with
n overall increase in speciﬁc productivity of 1.7 fold. LC–MS based
onitoring of the produced IgG conﬁrmed no detection of SSC con-
aining peptides, conﬁrming that the molecule is not integrated
n its native form into the mAb. To understand the mechanism of
ncreased titer, several experiments were performed to monitor
he oxidative status of cells. Intracellular labelling with Carboxy-
2DCFDA demonstrated a decreased generation of ROS in cells
f the SSC-containing process, indicating an overall anti-oxidative
roperty of the molecule. Several studies have already linked SSC to
nti-oxidative mechanisms. In plants, SSC was identiﬁed as essen-
ial component in light-dependent redox regulation within the
hloroplast of Arabidopsis thaliana (Bermudez et al., 2010). The
bsence of SSC synthase activity in chloroplasts was shown to
isturb the detoxiﬁcation of ROS, thus preventing the plant from
efending itself from the photochemical damage produced during
ong-day photoperiod (Gotor and Romero, 2013). The authors pos-
ulated that SSC may  act as a mild oxidant in the lumen, inducing
edox changes to activate regulatory proteins, important to protect
lants against photo-oxidative damage (Gotor and Romero, 2013).
To further explore the mechanism of SSC anti-oxidative activ-
ty, microarrays were performed on CHO cells extracted at different
ime points in a fed-batch process. The highest up-regulated gene in
he SSC condition compared to the control was coding for the SOD-
. Superoxide dismutases are anti-oxidant enzymes, which catalyze
he conversion of superoxide radicals to H2O2 and O2 (McCord and
ridovich, 1969). Like glutathione peroxidase and catalase, they are
nown to decrease intracellular ROS levels (Mannarino et al., 2011)
nd may, at least in part, be responsible for the lower intracellular
nti-oxidative potential observed in CHO cells. Interestingly, the
efect in photosynthesis observed in cs26 mutant plants (not pro-
ucing SSC) led to an increase in the production of ROS, such as
he superoxide radical anion and hydrogen peroxide (Gotor and
omero, 2013), conﬁrming the positive effect of SSC on SOD activ-
ty.
Even though the presented microarray study did not show any
odiﬁcation of the gene expression of enzymes involved in GSH
ynthesis, the free glutathione pool was quantiﬁed during the fed-
atch process. The results indicate that CHO cells cultivated in the
resence of SSC have an increased glutathione pool throughout the
ulture. This increased total glutathione may  explain the longer
ulture duration observed when using SSC, since GSH is the main
ellular antioxidant used to detoxify the cell by its conjugation
o xenobiotics catalyzed by glutathione S transferase or through
irect scavenging of free radicals and other ROS (Marí et al., 2009).
oreover, GSH can protect proteins against oxidative damage byorming reversible mixed disulﬁdes with cysteine residues. This
rocess of protein glutathionylation is likely to reduce oxidative
tress, potentially causing cellular apoptosis and growth limita-
ion in the fed-batch cultures (Selvarasu et al., 2012) and was alsohnology 218 (2016) 53–63
recently linked to increased energy generation mediated by GSH-
AMPK or GSH-UCP3 adducts (Mailloux et al., 2011; Zmijewski et al.,
2010).
Finally, the glutathione pool, or more generally the intracel-
lular redox status of the cells, may  be the key element being
responsible for the prolonged viability as described in the literature
(Banerjee, 2012), but also for the increase in titer observed in the
SSC-containing process. Several omics studies identiﬁed an upreg-
ulated GSH pathway in high producing CHO cells. For example,
the transcriptomic analysis of CHO cells, overexpressing the tau-
rine transporter, indicated a correlation between higher viability
and product yield and GSH metabolism (Tabuchi et al., 2010). The
up-regulation of proteins involved in the GSH pathway were also
identiﬁed in high producers using proteomic approaches (Chong
et al., 2012; Orellana et al., 2015). While most of the authors cor-
related the beneﬁcial effect of GSH to its protective effect against
oxidative stress damage, some additional factors such as the intra-
cellular redox status may  be implicated in the observed increase
in titer (Templeton et al., 2013). Several studies indicated that the
productivity of CHO cells may be limited by protein folding in the
endoplasmic reticulum (ER) (Lappi and Ruddock, 2011; Mohan and
Lee, 2010; Mohan et al., 2007). In this compartment, an oxidiz-
ing environment is necessary to introduce disulﬁde bonds into the
secreted proteins. The maintenance of a favorable GSH/GSSG ratio
has been described as particularly important for the assembly of
mAbs. Indeed, GSH may  protect against hyperoxidizing conditions
in the ER by consuming excess oxidizing equivalents and may cor-
rect protein disulﬁde bond formation by isomerization or reduction
of incorrect disulﬁde bonds prior to degradation (Chakravarthi and
Bulleid, 2004; Cuozzo and Kaiser, 1999; Kojer and Riemer, 2014).
Moreover, since the depletion of GSH was linked to aggregate for-
mation and higher rate of incorrect folding of secreted proteins
(Chakravarthi and Bulleid, 2004; Molteni et al., 2004), the higher
intracellular free glutathione pool obtained in the SSC process may
be linked to an increased folding in the ER, resulting in a higher
secretory rate and ﬁnally higher titer. Overall, we propose that the
higher glutathione pool in cells fed with SSC induce a change in
redox potential impacting both, the cell viability and the production
machinery of the mAb, and in particular the folding in the ER.
To conclude, SSC is a promising l-cysteine substitute for cell cul-
ture media scientists interested in process simpliﬁcation but also in
process performance improvement. The molecule is highly stable
in both media and feed and when used in fed-batch processes, is
able to increase the cellular speciﬁc productivity. Its performance
is likely linked to anti-oxidative properties mediated by the induc-
tion of SOD enzymes and the maintenance of a high glutathione
pool throughout the cell culture process.
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